These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8491967)

  • 1. Mechanism of sodium retention and ascites formation in cirrhosis.
    Arroyo V; Ginès P
    J Hepatol; 1993; 17 Suppl 2():S24-8. PubMed ID: 8491967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites.
    Cárdenas A; Arroyo V
    Best Pract Res Clin Endocrinol Metab; 2003 Dec; 17(4):607-22. PubMed ID: 14687592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of ascites formation.
    Cárdenas A; Bataller R; Arroyo V
    Clin Liver Dis; 2000 May; 4(2):447-65. PubMed ID: 11232200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiopathology of ascites in portal hypertension.
    Michielsen PP
    Acta Gastroenterol Belg; 1996; 59(3):191-7. PubMed ID: 9015930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and treatment of ascites and the hepatorenal syndrome.
    Gentilini P; Laffi G
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):581-607. PubMed ID: 1421601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascites in liver diseases.
    Gentilini P; Laffi G
    Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V; Jiménez W
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.
    Bolognesi M; Di Pascoli M; Verardo A; Gatta A
    World J Gastroenterol; 2014 Mar; 20(10):2555-63. PubMed ID: 24627591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.
    Levy M; Wexler MJ
    J Lab Clin Med; 1978 Mar; 91(3):520-36. PubMed ID: 627753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV
    Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology of portal hypertension and mechanisms of sodium and water retention in cirrhosis].
    Garini G; Delsante M; Iannuzzella F
    Recenti Prog Med; 2011 Mar; 102(3):134-40. PubMed ID: 21572486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
    Simón MA; Díez J; Prieto J
    Gastroenterology; 1991 Nov; 101(5):1354-60. PubMed ID: 1936807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of ascites in cirrhosis. A unitary hypothesis.
    Stanley MM
    ASAIO Trans; 1989; 35(2):161-3. PubMed ID: 2659055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites].
    Peña JC
    Rev Invest Clin; 1995; 47(1):63-79. PubMed ID: 7777718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
    Schrier RW; Arroyo V; Bernardi M; Epstein M; Henriksen JH; Rodés J
    Hepatology; 1988; 8(5):1151-7. PubMed ID: 2971015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
    Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.